{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:48:04Z","timestamp":1785358084425,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trecan.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:25:03Z","timestamp":1774560303000},"page":"485-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting histological transformation"],"prefix":"10.1016","volume":"12","author":[{"given":"Ethan M.","family":"Earlie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Varmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-953X","authenticated-orcid":false,"given":"Ashley M.","family":"Laughney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.02.001_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMc053610","article-title":"EGFR mutations in small-cell lung cancers in patients who have never smoked","volume":"355","author":"Zakowski","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0010","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S1470-2045(14)71180-5","article-title":"Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin","volume":"16","author":"Oser","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1097-0045(1996)6+<3::AID-PROS2>3.0.CO;2-T","article-title":"Neuroendocrine differentiation and hormone-refractory prostate cancer","volume":"6","author":"Abrahamsson","year":"1996","journal-title":"Prostate Suppl."},{"key":"10.1016\/j.trecan.2026.02.001_bb0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eururo.2003.11.032","article-title":"Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy","volume":"45","author":"Hirano","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.18.01585","article-title":"EGFR-mutant adenocarcinomas that transform to small-cell lung cancer and other neuroendocrine carcinomas: clinical outcomes","volume":"37","author":"Marcoux","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.athoracsur.2014.02.075","article-title":"Histologic evolution from adenocarcinoma to squamous cell carcinoma after gefitinib treatment","volume":"99","author":"Hsieh","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.trecan.2026.02.001_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lungcan.2018.11.027","article-title":"Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor","volume":"127","author":"Park","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.trecan.2026.02.001_bb0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.radcr.2019.01.015","article-title":"Transformation of adenocarcinoma of prostate to squamous cell carcinoma following hormonal treatment: a case report and review of the literature","volume":"14","author":"Lee","year":"2019","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.trecan.2026.02.001_bb0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccell.2024.01.012","article-title":"Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer","volume":"42","author":"Tong","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3960\/jslrt.22046","article-title":"Histologic transformation of follicular lymphoma: pathologists\u2019 viewpoint","volume":"63","author":"Maeshima","year":"2023","journal-title":"J. Clin. Exp. Hematop."},{"key":"10.1016\/j.trecan.2026.02.001_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41698-023-00398-5","article-title":"Histological transformation to gliosarcoma with combined BRAF\/MEK inhibition in BRAF V600E mutated glioblastoma","volume":"7","author":"Nelson","year":"2023","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41392-024-01908-y","article-title":"CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation","volume":"9","author":"Quintanal-Villalonga","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.02.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf7006","article-title":"Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers","volume":"15","author":"Quintanal-Villalonga","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0080","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41467-022-29963-5","article-title":"ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer","volume":"13","author":"Nouruzi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.001_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc.2017.5","article-title":"Tissue-specific tumorigenesis: context matters","volume":"17","author":"Schneider","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.02.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1415","article-title":"Lineage-specific intolerance to oncogenic drivers restricts histological transformation","volume":"383","author":"Gardner","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2026.02.001_bb0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.05.011","article-title":"Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence","volume":"19","author":"Guerra","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","article-title":"A gene-environment-induced epigenetic program initiates tumorigenesis","volume":"590","author":"Alonso-Curbelo","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/science.add5327","article-title":"Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis","volume":"380","author":"Burdziak","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0120","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"6","author":"Niederst","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.001_bb0125","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0130","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2016.71.9096","article-title":"Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas","volume":"35","author":"Lee","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aat5749","article-title":"Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage","volume":"362","author":"Park","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0160","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-13-1982","article-title":"Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma","volume":"20","author":"Tan","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.001_bb0165","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/2159-8290.CD-20-1863","article-title":"Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation","volume":"11","author":"Quintanal-Villalonga","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.02.001_bb0170","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.4161\/cc.10.16.17012","article-title":"Characterization of the cell of origin for small cell lung cancer","volume":"10","author":"Park","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trecan.2026.02.001_bb0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","article-title":"Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung","volume":"19","author":"Sutherland","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0180","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.celrep.2020.02.052","article-title":"FGFR1 oncogenic activation reveals an alternative cell of origin of SCLC in Rb1\/p53 mice","volume":"30","author":"Ferone","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.02.001_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-025-09503-z","article-title":"Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer","volume":"647","author":"Ireland","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0190","doi-asserted-by":"crossref","first-page":"22300","DOI":"10.1073\/pnas.1821745116","article-title":"Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes","volume":"116","author":"Lazaro","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.02.001_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/ERC-11-0368","article-title":"Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway","volume":"19","author":"Chen","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.trecan.2026.02.001_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/aja.aja_128_18","article-title":"Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms","volume":"21","author":"Huang","year":"2019","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.trecan.2026.02.001_bb0205","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-020-01003-9","article-title":"Clinical and biological features of neuroendocrine prostate cancer","volume":"23","author":"Yamada","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.trecan.2026.02.001_bb0215","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1073\/pnas.0906850106","article-title":"Basal cells as stem cells of the mouse trachea and human airway epithelium","volume":"106","author":"Rock","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.02.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc3172","article-title":"Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus","volume":"371","author":"Zepp","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0225","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00018-012-0922-8","article-title":"Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells","volume":"69","author":"Curradi","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.trecan.2026.02.001_bb0230","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/273769a0","article-title":"Bombesin-like immunoreactivity in the lung","volume":"273","author":"Wharton","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0235","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1165\/rcmb.2013-0199OC","article-title":"Chemosensory functions for pulmonary neuroendocrine cells","volume":"50","author":"Gu","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1438188","article-title":"Pulmonary neuroendocrine cells: crucial players in respiratory function and airway-nerve communication","volume":"18","author":"Thakur","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.trecan.2026.02.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113286","article-title":"Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.02.001_bb0255","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1101\/gad.1417406","article-title":"Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors","volume":"20","author":"Politi","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2026.02.001_bb0260","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45571","article-title":"Club cells form lung adenocarcinomas and maintain the alveoli of adult mice","volume":"8","author":"Spella","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.trecan.2026.02.001_bb0265","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.465","article-title":"SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas","volume":"41","author":"Bass","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2026.02.001_bb0270","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.6695174","article-title":"Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient","volume":"223","author":"Santos","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0275","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.02.001_bb0280","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1101\/gad.973602","article-title":"p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas","volume":"16","author":"Singh","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.trecan.2026.02.001_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","article-title":"MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition","volume":"31","author":"Mollaoglu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0295","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41388-021-02070-3","article-title":"Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2026.02.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt3177","article-title":"MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues","volume":"11","author":"Freie","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2026.02.001_bb0305","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.trecan.2026.02.001_bb0310","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/1078-0432.CCR-17-2446","article-title":"Blocking the feedback loop between neuroendocrine differentiation and macrophages improves the therapeutic effects of enzalutamide (MDV3100) on prostate cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.001_bb0315","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0320","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1038\/s41467-021-26821-8","article-title":"Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.001_bb0325","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","article-title":"Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T-cell killing","volume":"28","author":"Hiatt","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.001_bb0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2022.09.005","article-title":"Unraveling tumor microenvironment of small-cell lung cancer: implications for immunotherapy","volume":"86","author":"Li","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0335","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0340","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1158\/1078-0432.CCR-22-3743","article-title":"Immunogenomic landscape of neuroendocrine prostate cancer","volume":"29","author":"Bhinder","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.02.001_bb0345","article-title":"Review of checkpoint inhibitor immunotherapy in neuroendocrine tumor of prostate and our experience in 2 cases","volume":"10","author":"Pokhrel","year":"2022","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"10.1016\/j.trecan.2026.02.001_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","article-title":"Tumors: wounds that do not heal-redux","volume":"3","author":"Dvorak","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2026.02.001_bb0355","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41416-021-01309-w","article-title":"Cancer metastasis as a non-healing wound","volume":"124","author":"Deyell","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2026.02.001_bb0360","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","article-title":"Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer","volume":"7","author":"Zou","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.02.001_bb0365","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.02.001_bb0375","article-title":"LIANA+: an all-in-one cell-cell communication framework","author":"Dimitrov","year":"2023","journal-title":"bioRXiv"},{"key":"10.1016\/j.trecan.2026.02.001_bb0380","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-024-07134-4","article-title":"Universal recording of immune cell interactions in vivo","volume":"627","author":"Nakandakari-Higa","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.02.001_bb0385","article-title":"Modelling multicellular coordination by bridging cell-cell communication and intracellular regulation through multilayer networks","author":"Trimbour","year":"2026","journal-title":"bioRXiv"},{"key":"10.1016\/j.trecan.2026.02.001_bb0390","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41587-019-0068-4","article-title":"Characterization of cell fate probabilities in single-cell data with Palantir","volume":"37","author":"Setty","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.trecan.2026.02.001_bb0395","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-021-01346-6","article-title":"CellRank for directed single-cell fate mapping","volume":"19","author":"Lange","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.02.001_bb0400","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/00401706.1994.10485840","article-title":"Archetypal analysis","volume":"36","author":"Cutler","year":"1994","journal-title":"Technometrics"},{"key":"10.1016\/j.trecan.2026.02.001_bb0405","article-title":"10\u00d7 Genomics gene expression flex is a powerful tool for single-cell transcriptomics of xenograft models","author":"Oriol Llora-Batlle","year":"2024","journal-title":"bioRXiv"},{"key":"10.1016\/j.trecan.2026.02.001_bb0410","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2019.01.022","article-title":"Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics","volume":"176","author":"Ludwig","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0415","article-title":"SpaceBar enables single-cell-resolution clone tracing with imaging-based spatial transcriptomics","author":"Kinsler","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.trecan.2026.02.001_bb0420","article-title":"Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities","volume":"5","author":"Desai","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2026.02.001_bb0425","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cell.2020.09.056","article-title":"Chromatin potential identified by shared single-cell profiling of RNA and chromatin","volume":"183","author":"Ma","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.02.001_bb0430","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.02.001_bb0435","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41576-023-00618-5","article-title":"Gene regulatory network inference in the era of single-cell multi-omics","volume":"24","author":"Badia","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.trecan.2026.02.001_bb0440","article-title":"NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer","author":"Li","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2026.02.001_bb0445","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/s41467-022-30416-2","article-title":"A conserved YAP\/Notch\/REST network controls the neuroendocrine cell fate in the lungs","volume":"13","author":"Shue","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:59:51Z","timestamp":1781060391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2405803326000324"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.02.001","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting histological transformation","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}